Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
|
Mar 2021
|
Cancers
|
chronic myelomonocytic leukaemia (CMML), myelodysplastic syndromes (MDS)
|
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki
|
Oct 2016
|
Cancer Sci.
|
myelodysplastic syndromes (MDS)
|
Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia
|
Jun 2016
|
Cancer Res.
|
myelodysplastic syndromes (MDS)
|
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
|
Dec 2020
|
Cancer Medicine
|
myelodysplastic syndromes (MDS)
|
Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
|
Feb 2019
|
Cancer Med
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen
|
Oct 2017
|
Cancer Med
|
myelodysplastic syndromes (MDS)
|
Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options
|
Jan 2021
|
Cancer Management and Research
|
myelodysplastic syndromes (MDS)
|
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia
|
Feb 2015
|
Cancer Genet
|
aplastic anemia
|
Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients
|
Feb 2015
|
Cancer Epidemiol
|
myelodysplastic syndromes (MDS)
|
Evaluation of epidemiological factors in survival of patients with de novo myelodysplastic syndromes
|
Jan 2014
|
Cancer Causes Control
|
myelodysplastic syndromes (MDS)
|